Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05541887 · ClinicalTrials.gov registry record · NA

Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health

A NA study of Anxiety and Mood, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05541887 is a NA study of Anxiety and Mood that is actively recruiting participants, run by University of Florida. The registered enrollment target is 25 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05541887, a NA study of Anxiety and Mood, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

Previous studies have shown that polyphenol-rich foods can positively affect cognitive functions, memory, and mood in humans. We hypothesize that both acute and chronic intake of muscadine wine polyphenols will improve cognitive performance and mood through regulating the HPA axis, alleviating inflammation and oxidative stress, and/or inhibiting monoamine oxidase activities

Interventions

  • OTHER Placebo
  • OTHER Muscadine Wine Polyphenol

Study Locations (1)

Florida

  • Food Science and human nutrition department at University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2023-08-30
Est. Completion 2026-12
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05541887

The ClinicalTrials.gov registry entry for NCT05541887 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05541887 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05541887 about?

NCT05541887 is a clinical study titled "Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health". Previous studies have shown that polyphenol-rich foods can positively affect cognitive functions, memory, and mood in humans. We hypothesize that both acute and chronic intake of muscadine wine polyphenols will improve cognitive performance and mood through regulating the HPA axis, alleviating infla...

What is the current status of trial NCT05541887?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-08-30. Estimated completion is 2026-12.

What conditions does trial NCT05541887 study?

This clinical trial studies the following conditions: Anxiety, Mood, Memory, Cognitive Performance.

What interventions are being tested in trial NCT05541887?

The interventions under investigation include: Placebo (OTHER), Muscadine Wine Polyphenol (OTHER).

Who is sponsoring clinical trial NCT05541887?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05541887 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.